Subscribe To Our Free Newsletter |
Alembic Pharma records 48% growth in Q3 PAT
The drug maker recorded 48.01% jump in consolidated net profit to Rs 180.45 crore in Q3 FY23 as compared with Rs 121.92 crore in Q3 FY22.